Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.16%, EPS grew 133.3% and free cash flow grew 60.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

39.41 0.27 −0.68%
Market cap
$2.5B
P/E
37.5×
Fwd P/E
39.5×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

40.35 38.09 44.31 39.88
P/S ratio
1.17 1.30 1.64 1.81
P/FCF ratio
23.90 23.26 33.93 33.23
P/Operating CF
57.85 54.25 393.38 88.31
P/B ratio
8.34 8.61 10.26 10.29
EV/Sales
1.17 1.28 1.62 1.78
EV/EBITDA
20.28 19.47 23.49 23.90
EV/FCF
23.93 22.92 33.56 32.59
Current Ratio
1.22 1.38 1.46 1.65
Net Debt/EBITDA
(1.64) (1.80) (2.74) (3.40)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
2.48% 2.63% 2.26% 2.51%
Free Cash Flow Yield
4.18% 4.30% 2.95% 3.01%
Free Cash Flow per Share
0.37 0.49 0.02 0.40
Book value per Share
3.15 3.49 3.67 4.07
Free Cash Flow
22.96 30.37 1.31 25.14
EV/EBIT
27.80 25.45 30.48 30.44
Other line items

Show all line items

Columns are period end dates